| Literature DB >> 31071160 |
Jessica Ares, Sergio Valdés, Patricia Botas, Cecilia Sánchez-Ragnarsson, Sandra Rodríguez-Rodero, Paula Morales-Sánchez, Edelmiro Menéndez-Torre, Elías Delgado.
Abstract
[This corrects the article DOI: 10.1371/journal.pone.0211070.].Entities:
Year: 2019 PMID: 31071160 PMCID: PMC6508620 DOI: 10.1371/journal.pone.0216629
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 2HR (95% CI) for all-cause mortality depending on gender and presence of known or undiagnosed T2D.
Model adjusted for gender, age, body mass index, history of previous cardiovascular disease, history of high blood pressure, smoking, low density lipoprotein cholesterol and estimated glomerular filtration rate.
Fig 3HR (95% CI) for cardiovascular mortality depending on gender and presence of known or undiagnosed T2D.
Fig 4HR (95% CI) for Cancer mortality depending on gender and presence of known or undiagnosed T2D.